Results 11 to 20 of about 2,119,229 (358)

MRI-targeted or standard biopsy for prostate-cancer diagnosis [PDF]

New England Journal of Medicine, 2018
Background Multiparametric magnetic resonance imaging (MRI), with or without targeted biopsy, is an alternative to standard transrectal ultrasonography-guided biopsy for prostate-cancer detection in men with a raised prostate-specific antigen level who ...
Allen, Clare, Bladou, Franck, Borghi, Marcelo, Boxler, Silvan, Brew-Graves, Chris, Briganti, Alberto, Budäus, Lars, Campa, Riccardo, Catalano, Carlo, Crouzet, Sébastien, D'Eramo, Giuseppe, Deeks, Jonathan, Del Monte, Maurizio, Eggener, Scott, Emberton, Mark, Freeman, Alex, Ghei, Maneesh, Giganti, Francesco, Gill, Inderbir, Grompone, Marcello Domenico, Hadaschik, Boris A, Hellawell, Giles, Hindley, Richard G, Jim C, Hu, Kasivisvanathan, Veeru, Klotz, Laurence, Leonardo, Costantino, Margolis, Daniel, Moore, Caroline M, Morris, Stephen, Mynderse, Lance A, Panebianco, Valeria, Pinto, Peter, Precision, Study Group Collaborators, Punwani, Shonit, Rannikko, Antti S, Robert, Grégoire, Roobol, Monique J, Ruffion, Alain, Salvo, Vincenzo, Sciarra, Alessandro, Singh, Paras B, Takwoingi, Yemisi, Taneja, Samir S, Vaarala, Markku H, Venderink, Wulphert, Villeirs, Geert M, Villers, Arnauld, Virdi, Jaspal, Williams, Norman R   +49 more
core   +2 more sources

Exosomes as a new frontier of cancer liquid biopsy

Molecular Cancer, 2022
Liquid biopsy, characterized by minimally invasive detection through biofluids such as blood, saliva, and urine, has emerged as a revolutionary strategy for cancer diagnosis and prognosis prediction.
Dan Yu, Yixin Li, Maoye Wang, Jianmei Gu, Wenrong Xu, Huisi Cai, Xinjian Fang, Xu Zhang   +7 more
semanticscholar   +1 more source

Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments

Molecular Cancer, 2022
Over the past decade, invasive techniques for diagnosing and monitoring cancers are slowly being replaced by non-invasive methods such as liquid biopsy.
S. N. Lone, Sabah Nisar, Tariq Ahmad Masoodi, Mayank Singh, Arshi Rizwan, Sheema Hashem, W. El-Rifai, D. Bedognetti, S. Batra, Mohammad Haris, A. Bhat, M. Macha   +11 more
semanticscholar   +1 more source

Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring

Molecular Cancer, 2022
Primary lung cancer is one of the most common malignant tumors in China. Approximately 60% of lung cancer patients have distant metastasis at the initial diagnosis, so it is necessary to find new tumor markers for early diagnosis and individualized ...
Wen Li, Jibin Liu, L. Hou, Fei Yu, J. Zhang, Wei Wu, Xiao Tang, Feng Sun, Hai-Min Lu, Jing Deng, Jie Bai, Juan Li, Chun-yan Wu, Qin-Lu Lin, Zhongdong Lv, Gao-Ren Wang, Geng-Xi Jiang, Yu-Shui Ma, Da Fu   +18 more
semanticscholar   +1 more source

Liquid biopsy: current technology and clinical applications

Journal of Hematology & Oncology, 2022
Liquid biopsies are increasingly used for cancer molecular profiling that enables a precision oncology approach. Circulating extracellular nucleic acids (cell-free DNA; cfDNA), circulating tumor DNA (ctDNA), and circulating tumor cells (CTCs) can be ...
M. Nikanjam, S. Kato, R. Kurzrock
semanticscholar   +1 more source

MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis.

New England Journal of Medicine, 2020
BACKGROUND The use of 12-core systematic prostate biopsy is associated with diagnostic inaccuracy that contributes to both overdiagnosis and underdiagnosis of prostate cancer.
M. Ahdoot, Andrew R Wilbur, Sarah E Reese, A. Lebastchi, Sherif Mehralivand, Patrick T. Gomella, Jonathan B Bloom, Sandeep Gurram, M. Siddiqui, P. Pinsky, H. Parnes, W. Linehan, M. Merino, P. Choyke, J. Shih, B. Turkbey, B. Wood, P. Pinto   +17 more
semanticscholar   +1 more source

Mortality in Biopsy-Confirmed Nonalcoholic Fatty Liver Disease

Gut, 2020
Objective Population-based data are lacking regarding the risk of overall and cause-specific mortality across the complete histological spectrum of non-alcoholic fatty liver disease (NAFLD).
Tracey G. Simon, B. Roelstraete, H. Khalili, H. Hagström, J. Ludvigsson   +4 more
semanticscholar   +1 more source

Application of exosomes as liquid biopsy in clinical diagnosis

Signal Transduction and Targeted Therapy, 2020
Liquid biopsy refers to the sampling and molecular analysis of the biofluids of circulating tumor cells, extracellular vesicles, nucleic acids, and so forth. Exosomes are small extracellular vesicles with sizes between 30–150 nm.
Biting Zhou, Kailun Xu, Xi Zheng, Ting Chen, Jian Wang, Yong-mao Song, Yingkuan Shao, Shu Zheng   +7 more
semanticscholar   +1 more source

Kidney Biopsy Findings in Patients with COVID-19.

Journal of the American Society of Nephrology, 2020
BACKGROUND Coronavirus disease 2019 (COVID-19) is thought to cause kidney injury by a variety of mechanisms. To date, pathologic analyses have been limited to patient reports and autopsy series.
Satoru Kudose, Ibrahim Batal, D. Santoriello, Katherine Xu, J. Barasch, Yonatan Peleg, P. Canetta, Lloyd E. Ratner, M. Marasà, A. Gharavi, M. Stokes, G. Markowitz, V. D'Agati   +12 more
semanticscholar   +1 more source

Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial.

JAMA Oncology, 2021
Importance Magnetic resonance imaging (MRI) with targeted biopsy is an appealing alternative to systematic 12-core transrectal ultrasonography (TRUS) biopsy for prostate cancer diagnosis, but has yet to be widely adopted. Objective To determine whether
L. Klotz, J. Chin, P. Black, A. Finelli, M. Anidjar, F. Bladou, Ashley Machado, M. Levental, S. Ghai, Sylvia Chang, L. Milot, C. Patel, Z. Kassam, Carolyn J. Moore, Veeru Kasivisanathan, A. Loblaw, M. Kebabdjian, C. Earle, G. Pond, M. Haider   +19 more
semanticscholar   +1 more source